
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated November 20, 2025, titled "SPARC announces Complete Response Letter Resubmission for PDP-716 NDA by Ocuvex".
Filed with NSE · · 2 pages · English

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated November 20, 2025, titled "SPARC announces Complete Response Letter Resubmission for PDP-716 NDA by Ocuvex".
Sun Pharma Advanced Research Co. Ltd. on 6ix
Follow Sun Pharma Advanced Research into a list and get an email when it puts out news.
Follow Sun Pharma Advanced Research